How This Works
TB‑500 represents the N‑terminal active fragment of thymosin beta‑4, specifically the heptapeptide sequence Ac‑LKKTETQ[1][2]. This region is responsible for the actin‑binding and cell‑migration properties of the full thymosin molecule. Preclinical studies demonstrate that TB‑500 promotes angiogenesis, accelerates wound healing, and supports tissue regeneration by upregulating cell motility and blood vessel formation[5][6]. Research in animal models shows enhanced collagen deposition and reduced healing time in injury sites treated with thymosin fragments[11]. Recent metabolic studies suggest TB‑500 may act as a prodrug, cleaving to an active pentapeptide metabolite that drives biological activity[12].
References
FASEB Journal
— Biological activities of thymosin β4 defined by active peptide sequences (TB‑500 fragment identification)
Journal of Chromatography A (PubMed)
— Doping control analysis of TB‑500 as synthetic thymosin β4 fragment in biological samples
WADA Scientific Research
— Investigation of TB‑500 metabolism, synthesis of metabolites, and detection limits
Racing Medication & Testing Consortium
— Thymosin β4 regulatory bulletin (TB‑500 use in equine sports medicine)
Journal of Investigative Dermatology (PubMed)
— Thymosin beta4 accelerates wound healing (preclinical wound healing model)
FASEB Journal (PubMed)
— Active site mapping of thymosin β4 fragments for angiogenesis and cell migration
Verified Peptides Storage Guide
— Lyophilized peptide storage best practices (temperature, humidity, light protection)
Empower Pharmacy
— Bacteriostatic water measurement guidelines (0.9% benzyl alcohol, multi‑dose vial stability)
NCBI Bookshelf
— Best practices for measurement (aseptic technique, site rotation)
WADA Prohibited List
— TB‑500 classification as prohibited substance in competitive sports
Journal of Investigative Dermatology
— Thymosin β4 wound healing mechanisms (collagen deposition, angiogenesis, granulation tissue)
Journal of Chromatography B (PubMed)
— Quantification of TB‑500 metabolites and wound healing activity screening (prodrug hypothesis)
CenterWatch Clinical Trials
— Clinical trial registry for thymosin β4 in acute myocardial infarction (no TB‑500 specific trials)
Nursing Journal (LWW)
— How to prepare measurements (clinical technique guidelines)
University of Michigan Health
— Research sample education guide for handling reference